Skip Navigation

European Heart Journal 2002 23(5):343-344; doi:10.1053/euhj.2001.2956
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wilhelmsen, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilhelmsen, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Inflammation, infection, and coronary heart disease

L. Wilhelmsen

Section of Preventive Cardiology, The Cardiovascular Institute, Göteborg University, Göteborg, Sweden

References

  1. Danesh J, Whincup P, Lewington S. Chlamydia pneumoniae IgA titres and coronary heart disease. Prospective study and meta-analysis. Eur Heart J. 2002;23:371–375[Abstract/Free Full Text]
  2. Wilhelmsen L. Coronary heart disease: epidemiology of smoking and intervention studies of smoking. Am Heart J. 1988;115:242–249[CrossRef][ISI][Medline]
  3. Böttiger LE, Carlson LA. Risk factors for ischaemic vascular death for men in the Stockholm prospective study. Atherosclerosis. 1980;36:389–408[CrossRef]
  4. Shah PK. Plaque disruption and thrombosis. Potential role of inflammation and infection. Cardiol Rev. 2000;8:31–39[CrossRef][Medline]
  5. Jahn J, Dalhoff K, Katus HA. Coronary artery disease: an inflammatory or infectious process. Basic Res Cardiol. 2000;95:59–64[CrossRef]
  6. Becker AE, de Boer OJ, van der Wall AC. The role of inflammation and infection in coronary artery disease. Annu Rev Med. 2001;52:289–297[CrossRef][ISI][Medline]
  7. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J. 1993;69:377–381[Abstract/Free Full Text]
  8. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:503–505[Free Full Text]
  9. Lee RT, Schoen RT, Loree HM, Lark MW, Libby P. Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis. Implications for plaque rupture. Arterioscler Thromb Vasc Biol. 1996;16:1070–1073[Abstract/Free Full Text]
  10. Saikku P, Leinonen M, Mattila K. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;8618:983–986
  11. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997;350:430–436[CrossRef][ISI][Medline]
  12. Mass M, Bartels C, Engel PM, Mamat U, Sievers HH. Endovascular presence of viable Chlamydia pneumoniae is a common phenomen in coronary artery disease. J Am Coll Cardiol. 1998;31:827–832[Abstract/Free Full Text]
  13. Muhlestein JB, Anderson JL, Hammond EH. Infection with Chlamydia pneumniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation. 1998;97:633–636[Abstract/Free Full Text]
  14. Moazed TC, Kuo C, Grayston JT, Campbell LA. Evidence of systemic dissemination of Chlamydia pneumomiae via macrophages in the mouse. J Infect Dis. 1997;177:1322–1325
  15. Kothe H, Dalhoff K, Rupp J. Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae. Circulation. 2000;101:1760–1763[Abstract/Free Full Text]
  16. Navab M, Berliner JA, Subbanagounder G. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler Thromb Vasc Biol. 2001;21:481–488[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wilhelmsen, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilhelmsen, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?